GF
JNP

Gabelli Funds’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Gabelli Funds’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-53,182
Closed -$253K – 1153
2017
Q1 		$253K Sell
53,182
-11,818
-18% -$59.7K ﹤0.01% 1075
2016
Q4 		$364K Hold
65,000
– – ﹤0.01% 1051
2016
Q3 		$361K Buy
65,000
+10,000
+18% +$66.1K ﹤0.01% 1057
2016
Q2 		$386K Hold
55,000
– – ﹤0.01% 1058
2016
Q1 		$364K Hold
55,000
– – ﹤0.01% 1039
2015
Q4 		$567K Buy
55,000
+10,046
+22% +$116K ﹤0.01% 983
2015
Q3 		$530K Sell
44,954
-79,142
-64% -$875K ﹤0.01% 932
2015
Q2 		$1.14M Sell
124,096
-9,213
-7% -$69.6K 0.01% 861
2015
Q1 		$828K Sell
133,309
-1,691
-1% -$10.5K ﹤0.01% 897
2014
Q4 		$756K Hold
135,000
– – ﹤0.01% 932
2014
Q3 		$795K Buy
135,000
+33,800
+33% +$206K ﹤0.01% 925
2014
Q2 		$693K Buy
101,200
+49,444
+96% +$331K ﹤0.01% 931
2014
Q1 		$373K Buy
+51,756
New +$358K ﹤0.01% 984

Other funds holding JNP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Gabelli Funds's JNP Position: Q2 2017 in Review

Gabelli Funds sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2017, closing a stake of 53,182 shares — an estimated $253K sold.

Gabelli Funds first reported a position in JNP in Q1 2014 and held it in 13 quarters. The position peaked at $1.14M in Q2 2015. 33 funds tracked by Wall St. Rank hold JNP as of Q2 2017.

  • Gabelli Funds reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Gabelli Funds sold 53,182 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2017, an estimated $253K.
  • Gabelli Funds first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2014 and held it in 13 quarters.
  • Gabelli Funds's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.14M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Gabelli Funds's 13F filing for Q2 2017, filed 3 Aug 2017.